An updated overview with simple and practical approach for developing in vitro-in vivo correlation.

Area of Science:

• Pharmaceutical Sciences
• Pharmacokinetics
• Drug Development

Background:

• In vitro-in vivo correlation (IVIVC) models are vital for optimizing pharmaceutical formulations.
• Validated IVIVC can act as a substitute for bioequivalence studies, reducing development costs.
• Current IVIVC approaches face challenges due to complexity and data fitting issues.

Purpose of the Study:

• To review IVIVC principles, development approaches, validation, and applications.
• To illustrate practical methods for predicting plasma drug levels and drug absorption.
• To recommend quality by design manufacturing and clinically relevant dissolution specifications.

Main Methods:

• Discussion of different IVIVC correlation levels and general development strategies.
• Illustration of convolution and deconvolution techniques for predicting pharmacokinetic parameters.
• Review of validation, data analysis, and applications of IVIVC models.

Main Results:

• A simplified approach using convolution and deconvolution is presented for practical IVIVC.
• Pharmacokinetic parameters like Cmax, Tmax, and AUC are key for bioavailability assessment.
• In silico/physiologically based pharmacokinetic modeling is increasingly recognized by regulatory agencies.

Conclusions:

• Implementing IVIVC can significantly streamline pharmaceutical product development and evaluation.
• Quality by Design (QbD) manufacturing ensures consistent product quality and bioperformance.
• Regulatory bodies advocate for advanced modeling techniques to ensure clinical performance prediction.